TITLE

Optimizing the use of prescription drugs in Canada through the Common Drug Review

AUTHOR(S)
Tierney, Mike; Manns, Braden
PUB. DATE
February 2008
SOURCE
CMAJ: Canadian Medical Association Journal;2/12/2008, Vol. 178 Issue 4, p432
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article focuses on the optimization of the use of prescription drugs in Canada through the Common Drug Review of the Canadian Agency for Drugs and Technologies in Health. The review acknowledges that health care budgets are limited and that funding new medication may suggest foregoing other effective therapies. It is analyzing the cost-effectiveness of new medications. The Canadian Expert Drug Advisory Committee made recommendations for formulary listings to participating drug plans based on effectiveness, safety and cost-effectiveness of medications.
ACCESSION #
28802123

 

Related Articles

  • Non-U.S. Clinical Trials And Regulatory Actions: December 2009.  // BioWorld Insight;1/25/2010, Vol. 18 Issue 4, p30 

    The article presents the update of non-U.S. clinical trials and regulatory actions as of December 2009. The Toctino drug to treat severe chronic hand eczema from Basilea Pharmaceutica Ltd. is recommended for regulatory approval. It notes that The Medicines Co.'s Angiox drug for heart attack...

  • IT'S THE ANTIGEN STUPID: A RISK/REWARD APPROACH TO THE PROBLEM OF ORPHAN DRUG ACT EXCLUSIVITY FOR MONOCLONAL ANTIBODY THERAPEUTICS. Bohrer, Robert A. // Columbia Science & Technology Law Review;2008, Vol. 9, p1 

    The Orphan Drug Act of 1983 is an attempt at solving an important problem: how to induce a market-driven pharmaceutical industry to develop new therapeutics for diseases affecting relatively small numbers of persons. In the case of protein therapeutics produced by biotechnology, the FDA's...

  • Definition of Medication Therapy Management: Development of Professionwide Consensus. Bluml, Benjamin M. // Journal of the American Pharmacists Association: JAPhA;Sep/Oct2005, Vol. 45 Issue 5, p566 

    Objective: To describe events leading to development of a professionwide consensus definition of medication therapy management (MTM) and attendant programs and services and present the document (definition, services, and program requirements) resulting from the process. Data Sources: Author's...

  • IT'S SHOW TIME. Ulkens, Carol // Drug Topics;11/6/2006, Vol. 150 Issue 21, p30 

    The article discusses ways to improve the current pharmacy business model of making money from selling drugs in the U.S. Researchers believe that providing face-to-face medication therapy management (MTM) services is beneficial in demonstrating the value community pharmacists to its clients....

  • Formulary Management.  // Best Practices for Hospital & Health-System Pharmacy;2007/2008, p115 

    The article presents several medical use policies in establishing an effective and beneficial formulary management in the U.S. The Council on Professional Affairs aims to advocate that the pharmacists should have an access to the intended therapeutic purpose of prescribed medications to ensure...

  • Methods for Benefit and Risk Assessment of Drugs. Ngorsuraches, Surachat // South Dakota Medicine;Aug2015, Vol. 68 Issue 8, p363 

    The article deals with two emerging preference elicitation methods, discrete choice experiment (DCE) and multi-criteria decision analysis (MCDA), that have been increasingly used in the quantitative benefit and risk assessment of drugs. Topics discussed include the enhancements made on the...

  • Comparison of provincial prescription drug plans and the impact on patients' annual drug expenditures. Demers, Virginie; Melo, Magda; Jackevicius, Cynthia; Cox, Jafna; Kalavrouziotis, Dimitri; Rinfret, Stéphane; Humphries, Karin H.; Johansen, Helen; Tu, Jack V.; Pilote, Louise // CMAJ: Canadian Medical Association Journal;2/12/2008, Vol. 178 Issue 4, p405 

    Background: Reimbursement for outpatient prescription drugs is not mandated by the Canada Health Act or any other federal legislation. Provincial governments independently establish reimbursement plans. We sought to describe variations in publicly funded provincial drug plans across Canada and...

  • Jóvenes en el narcomenudeo: el caso Ciudad de México. Zamudio Angles, Carlos Alberto // URVIO - Revista Latinoamericana de Seguridad Ciudadana;jun2014, Issue 13, p111 

    The aim of this article is to explain how young persons in Mexico City are inserted in the illicit small-scale drug market, and how their participation influences in expansion local drug markets. For this purpose, the different modalities used in the drug trade are described, and the role taken...

  • WHO launches taskforce to fight counterfeit drugs. Burns, William // Bulletin of the World Health Organization;Sep2006, Vol. 84 Issue 9, p689 

    The article announces the establishment of the International Medical Products Anti-Counterfeiting Taskforce program which aims to stop the trade of counterfeit drugs. The World Health Organization (WHO) launches the taskforce which will be composed of national drug regulatory authorities as well...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics